Literature DB >> 3887980

Radiometric oil well assay for glucokinase in microscopic structures.

F J Bedoya, M D Meglasson, J M Wilson, F M Matschinsky.   

Abstract

Glucokinase (ATP:D-glucose 6-phosphotransferase, EC 2.7.1.1) plays a pivotal role in hepatic glucose metabolism and serves as the glucose sensor in pancreatic islet beta-cells. Biochemical studies of this enzyme are complicated by the cellular heterogeneity of the liver and the pancreas and because the presence of hexokinases (ATP:D-hexose 6-phosphotransferases, EC 2.7.1.1) seriously interferes with currently available analytical procedures. A radiometric assay was designed to deal with these problems. It is based on the liberation of 3H2O from D-[2-3H(N)]glucose 6-phosphate, the product of the glucokinase reaction, using exogenous phosphoglucose isomerase (D-glucose-6-phosphate ketol-isomerase, EC 5.3.1.9). Interference by hexokinases was largely eliminated by using glucose 6-phosphate as inhibitor and the sensitivity of the assay was greatly increased by using small volumes with the oil well procedure. The assay was sufficiently sensitive to detect about 1 pg of glucokinase. It thus allowed the application of quantitative histochemical procedures to the study of intralobular hepatic glucokinase profiles and the pancreatic beta-cell glucose sensor. The quantitative histochemical procedures were sufficiently sensitive and reliable for measuring important kinetic constants of glucokinase (i.e., the Km and the Hill number) in microscopic samples of tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887980     DOI: 10.1016/0003-2697(85)90147-2

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

Review 1.  Mammalian glucokinase and its gene.

Authors:  P B Iynedjian
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

2.  Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2).

Authors:  P Kesavan; L Wang; E Davis; A Cuesta; I Sweet; K Niswender; M A Magnuson; F M Matschinsky
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

3.  In situ glucose uptake and glucokinase activity of pancreatic islets in diabetic and obese rodents.

Authors:  Y Liang; S Bonner-Weir; Y J Wu; C D Berdanier; D K Berner; S Efrat; F M Matschinsky
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

4.  Expression of yeast hexokinase in pancreatic beta cells of transgenic mice reduces blood glucose, enhances insulin secretion, and decreases diabetes.

Authors:  P N Epstein; A C Boschero; I Atwater; X Cai; P A Overbeek
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

5.  Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes.

Authors:  P B Iynedjian; S Marie; A Gjinovci; B Genin; S P Deng; L Buhler; P Morel; G Mentha
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.